Corcept Therapeutics
CORT
CORT
209 hedge funds and large institutions have $1.94B invested in Corcept Therapeutics in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 89 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
30% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 89
41% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 37
71% less funds holding in top 10
Funds holding in top 10: 7 → 2 (-5)
Holders
209
Holding in Top 10
2
Calls
$12.5M
Puts
$9.73M
Top Buyers
| 1 | +$14.9M | |
| 2 | +$9.32M | |
| 3 | +$8.58M | |
| 4 |
AWS
AJ Wealth Strategies
New York
|
+$6.44M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$4.45M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$8.46M | |
| 3 | -$7.77M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$6.71M |
| 5 |
D.E. Shaw & Co
New York
|
-$6.11M |